$CROX

Crocs Soars 18% on Third Straight Guidance Raise as HEYDUDE Hits “An Important Milestone”

Crocs (CROX) stock rose 18% after Q3 earnings beat and raised full-year guidance for the third time. Revenue increased 5% to $1.04B, with Crocs brand up 4% and HEYDUDE up 6%. North America sales fell 2%, while international grew 12%. HEYDUDE's growth came from retailer orders, not direct sales. The company now expects 2026 adjusted EPS of $14.45-$14.65, up from prior guidance.

Original reporting
Published Oct 29, 2026, 4:59 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 5:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Crocs Soars 18% on Third Straight Guidance Raise as HEYDUDE Hits “An Important Milestone” — source image
Decision brief

The 30-second read

$CROXBullishHigh
01

Why it matters

The earnings beat and guidance raise triggered an 18% intraday rally, indicating strong market reaction.

02

Market read

The surprise earnings and guidance lift make Crocs a high‑impact trade idea today.

03

What to watch

HEYDUDE growth is retailer‑driven; lack of direct‑to‑consumer momentum may cap long‑term expansion.

Relevance 9/10Novelty 9/10Timing: today

Background

Crocs' earnings release included a 5% revenue increase to $1.04 bn, EPS of $3.69 versus $3.31 consensus, and a new 2026 EPS outlook of $14.45‑$14.65.

Company-level read

Ticker impact

$CROXBullishHigh confidence
Context

Crocs reported Q3 earnings beat and raised full-year guidance, sending the stock up 18% on the day.

Expected impact

upward pressure as investors price in higher earnings outlook

Evidence & confidence

The surprise EPS beat and raised EPS guidance for 2026 are fresh, material facts that moved the stock 18% intraday.

Market effects

Footwear and apparel sector may see renewed optimism as a leading brand demonstrates growth.

North America weakness offset by strong international sales, highlighting regional demand shifts.

Crocs' guidance raise contributes to broader consumer discretionary sentiment.

Counterpoint

The 2% decline in North America sales could signal underlying demand weakness that may limit upside.

Key entities

  • Crocs

    Footwear manufacturer reporting earnings and guidance.

Related articles

$CROXMed

UBS raises Crocs stock price target to $145 on strong results

UBS raised its price target on Crocs (CROX) to $145 from $120, citing strong Q3 results and raised guidance. The stock has surged 26% in a week. UBS noted macro uncertainty but sees balanced risk. Crocs reported adjusted earnings of $3.69 per share and revenue of $1.04B, exceeding expectations. Goldman Sachs also raised its target to $128 but maintained a Sell rating.

$CROXMed

Goldman Sachs raises Crocs stock price target on growth outlook

Goldman Sachs raised its price target on Crocs (CROX) to $128 from $95, citing stronger growth, improved profitability, and a positive outlook. The stock has surged 75.7% year-to-date. Crocs reported stronger-than-expected Q3 results, with adjusted earnings of $3.69 per share and revenue of $1.04 billion, raising its full-year outlook. The HEYDUDE brand showed positive performance after two years of negative results.

$CROXHighAI 9/10

"I thought ugly shoes were a thing of the past"... Crocs shares stage stunning turnaround after plunging 30%

Crocs shares surged 25.54% to $150.26 after strong Q3 results and an upgraded full-year outlook. Adjusted EPS of $3.69 beat estimates, and revenue reached $1.04 billion. HEYDUDE, a subsidiary, saw a 6.1% revenue increase. CEO Andrew Rees cited growth across brands and regions. Last year, shares plunged 30% due to weak guidance and market trends.